Learn More About Janssen's Phase 3 COVID-19 Vaccine Candidate Clinical Trials Please note that by clicking this link, you’ll be leaving jnj.com and going to a third-party website not governed by the jnj.com privacy policy.
With COVID-19 dominating the news this year, chances are you've also read about clinical studies that are underway for investigational vaccines. For a glimpse at what the experience of participating in a clinical study is like, we spoke to people across the country who took part in a clinical trial.
It's one hard-working organ, pumping 1.5 gallons of blood every minute and beating around 100,000 times a day. In honor of American Heart Month, we sat down with a ticker expert to learn about things most people may not know about their hearts—and advances that could change cardiac care.
Helping change the trajectory of health for humanity is a lofty goal—and it's one Johnson & Johnson is deeply devoted to. Just read these moving stories, from a boy who benefited from spinal surgery to a woman who survived a stroke at 37.
It's a lofty goal: improve the health, across the board, of future generations. But it's a mission that Johnson & Johnson is committed to. And thanks to groundbreaking work taking place across the company—from vaccine development to consumer product innovation—the future is looking very bright.
It's a deadly disease, but it can be managed—if you get a timely diagnosis. For World Heart Day, we're sharing what the latest science and research has revealed about PAH, including who is most at risk and the warning signs to look out for.
Joaquin Duato, Executive Vice President and Worldwide Chairman, Pharmaceuticals, shares how the transaction will help expand the company's portfolio of transformational therapies.